Stephen D. Smith

Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa

Also affiliated with University of Washington, Fred Hutch Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 study”.

Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 study

The Lancet Haematology(2021)10.1016/s2352-3026(21)00170-8

N/A

1.6DataRank · unranked

59 citations

Ryan D. Cassaday, Stephen D. Smith, Jonathan R. Fromm, Andrew J. Cowan, Edus H. Warren +15 more

Concurrent pembrolizumab with AVD for untreated classical Hodgkin lymphoma

Blood(2023)10.1182/blood.2022019254

N/A

1.4DataRank · unranked

39 citations

Chaitra S. Ujjani, Christina Poh, Edus H. Warren, Stephen D. Smith, Mazyar Shadman +21 more

Hypertension treatment for patients receiving ibrutinib: a multicenter retrospective study

Blood Advances(2024)10.1182/bloodadvances.2023011569

N/A

0.373DataRank · unranked

11 citations

Jenna Voutsinas, Bita Fakhri, Sirin Khajavian, Stephen E. Spurgeon, Deborah M. Stephens +30 more

A multiplexed assay for quantifying immunomodulatory proteins supports correlative studies in immunotherapy clinical trials

Frontiers in Oncology(2023)10.3389/fonc.2023.1168710

N/A

0.269DataRank · unranked

5 citations

Lei Zhao, Regine M. Schoenherr, Dongqing Huang, Rachel A. Lundeen, Ulianna Voytovich +24 more

Efficacy, safety, and molecular response predictors of oral ixazomib and short-course rituximab in untreated iNHL

Blood Advances(2022)10.1182/bloodadvances.2022008628

N/A

0.240DataRank · unranked

3 citations

Ryan C. Lynch, Chaitra S. Ujjani, Ted Gooley, Heather Rasmussen, David G. Coffey +9 more

The impact of histological grade on outcomes in follicular lymphoma: An analysis of patients in the SEER database in the context of evolving disease classification and treatment

British Journal of Haematology(2022)10.1111/bjh.18404

N/A

0DataRank · unranked

18 citations

Ted Gooley, Keith R. Loeb, Lorinda Soma, Stephen D. Smith, Ajay K. Gopal +2 more

Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study

Haematologica(2021)10.3324/haematol.2020.270876

N/A

0DataRank · unranked

42 citations

Andrew M. Evens, Alexey V. Danilov, Stephen D. Smith, Deepa Jagadeesh, Lori A. Leslie +52 more

Long-term efficacy and safety of pembrolizumab with R-CHOP as first-line therapy for DLBCL.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.7561

N/A

0DataRank · unranked

1 citations

Jonathan R. Fromm, Min Fang, Brian G. Till, Mazyar Shadman, Andrew J. Cowan +11 more